Do Sung Huh | Functional polymer | Best Researcher Award

Posted on by ScienceFather

Prof. Do Sung Huh | Functional polymer | Best Researcher Award

PHD at KAIST, South Korea

Prof. Do Sung Huh is a distinguished professor at Inje University, specializing in Polymer Physical Chemistry. With a B.S. from Seoul National University and an M.S. and Ph.D. from KAIST, his research focuses on the fabrication and functionalization of honeycomb-patterned porous films via the Breath Figure method. He has published extensively on topics including pore-selective functionalization, metal functionalization, and smart materials. Prof. Huh has served as Dean of the College of Natural Science and is currently part of the Department of Radiational Chemistry. His work has significant implications for antibacterial applications and glucose sensing.

Professional Profiles

Education

B.S. Department of Chemical Education, Seoul National University M.S. Department of Chemistry, KAIST Ph.D. Department of Chemistry, KAIST

Professional Experience

1989.03 – present: Professor of Inje University 2011.03 – 2015: Dean of College of Natural Science 2022.03 – Present: Department of Radiational Chemistry

Research Interests

Fabrication of Honeycomb-patterned (HCP) Porous Films by Breath Figure (BF) method Pore-selective functionalization Pore-selective metal functionalization & anti-bacterial applications Pore-selective modification of smart materials Glucose sensing by the fractal polyaniline (PANI) structure in the honeycomb-patterned porous film

Lab Interest Areas

Pore-selective functionalization Pore-selective metal functionalization & anti-bacterial applications Pore-selective modification of smart materials Glucose sensing by the fractal polyaniline (PANI) structure in the honeycomb-patterned porous film

Research Focus

Prof. Do Sung Huh’s research primarily focuses on the fabrication and functionalization of advanced polymeric materials, particularly honeycomb-patterned porous films. His work leverages the Breath Figure method to achieve pore-selective functionalization, enabling applications in antibacterial coatings, smart materials, and glucose sensing. Additionally, Prof. Huh explores the synthesis and characterization of conducting polymers and their composites, such as polyaniline and polypyrrole, for use in supercapacitors, sensors, and other electronic devices. His studies also delve into the antibacterial properties of nanoparticle-embedded films and the development of functionalized nanocomposites for enhanced electrical and mechanical properties.

Publications

  1. Revival Oscillations in a Closed Bromate‐1, 4‐Cyclohexanedione‐Acid System with Ferroin, Publication date: 2021.
  2. Analysis of kinetic release of dye from the temperature-sensitive poly (N-isopropylacrylamide) functionalized porous polystyrene film, Publication date: 2022.
  3. Novel Capturer-Catalyst Microreactor System with a Polypyrrole/Metal Nanoparticle Composite Incorporated in the Porous Honeycomb-Patterned Film, Publication date: 2023.
  4. Thermo-responsive release of rhodamine B in the pore-selective poly(N-isopropylacrylamide) immobilized honeycomb-patterned porous film, Publication date: 2021.
  5. Experimental study on the detection of hazardous chemicals using alternative sensors in the water environment, Publication date: 2022.
  6. Flower-like ordered porous array by combination of breath figure and layer-by-layer technique, Publication date: 2021.
  7. Single-step pore-selective silver-functionalized honeycomb-patterned porous polystyrene film using a modified breath figure method, Publication date: 2021.
  8. Modified breath figure methods for the pore-selective functionalization of honeycomb-patterned porous polymer films, Publication date: 2022.
  9. Antibacterial activity of polyaniline coated in the patterned film depending on the surface morphology and acidic dopant, Publication date: 2022.
  10. Synthesis and characterization of polyaniline-grafted CNT as electrode materials for supercapacitors, Publication date: 2017.
.

Hongshan Li | Macromolecules | Best Researcher Award

Posted on by ScienceFather

Prof Dr. Hongshan Li | Macromolecules | Best Researcher Award

Director at Ningbo No. 2 Hospital, China

Dr. Hongshan Li, a distinguished expert in Traditional Chinese Medicine, serves as the Chief Physician and Director of the Liver Disease Department at Ningbo No. 2 Hospital. With a doctorate from Shanghai University of Traditional Chinese Medicine, he specializes in liver diseases. Dr. Li has led significant research projects funded by the National Natural Science Foundation of China and has been honored with multiple awards for his contributions to integrative medicine. He is also a doctoral supervisor and a prominent figure in Zhejiang Province’s medical community, recognized for his innovative approaches and leadership in liver disease diagnosis and treatment. Macromolecules

Professional Profiles

Education

Doctor of Internal Medicine of Traditional Chinese Medicine (Liver Disease) Institution: Shanghai University of Traditional Chinese Medicine Duration: September 2017 – June 2020 Master of Internal Medicine of Traditional Chinese Medicine (Liver Disease) Institution: Shanghai University of Traditional Chinese Medicine Duration: September 2005 – June 2008 Bachelor of Traditional Chinese Medicine Institution: Henan University of Chinese Medicine Duration: September 2000 – June 2005 Macromolecules

Professional Experience

Chief Physician of Traditional Chinese Medicine, Department Director Institution: Liver Disease Department of Integrative Medicine, Ningbo No. 2 Hospital Duration: January 2022 – Present Subject Leader, Department Director Institution: Liver Disease Department of Integrative Medicine, Ningbo No. 2 Hospital Duration: May 2020 – December 2021 Associate Director of Traditional Chinese Medicine Institution: Liver Disease Department of Integrative Medicine, Ningbo No. 2 Hospital Duration: January 2017 – April 2020 Traditional Chinese Medicine Physician, Attending Traditional Chinese Medicine Physician Institution: Liver Disease Department of Integrative Medicine, Ningbo No. 2 Hospital Duration: July 2008 – December 2016

Scientific Research Projects

National Natural Science Foundation of China (General Projects) Project: Study on the effect mechanism of HJJB formula in regulating hepatic lipid metabolism in NAFLD based on nuclear receptor FXR National Natural Science Foundation of China Youth Science Foundation Project Project: Study on the mechanism of the ‘HJJB’ compound in the prevention and treatment of NAFLD based on insulin signal transduction Zhejiang Natural Science Foundation Project Project: Study on the mechanism and main effect components of ‘HJJB’ compound in improving liver fat metabolism in NAFLD National Administration Of Traditional Chinese Medicine-Zhejiang Province Co-Construction Science and Technology Program Key Projects Project: Clinical efficacy evaluation and mechanism study of QTHX compound in the treatment of metabolic-related fatty liver disease Macromolecules

Titles and Honors

Doctoral Supervisor, Ningbo University Leading Medical and Health Talents, Zhejiang Province Chinese Medicine Innovation Team Leader, Zhejiang Province Key Laboratory Leader, Zhejiang Provincial Key Laboratory of Diagnosis, Treatment and Research of Digestive System Tumors High-Level Health Talent, Zhejiang Province Medical New Talent, Third Phase, Zhejiang Province Yongjiang Talent Project Leader and Top Talent First-Level Cultivation Object Ningbo Medical Key Discipline Leader (Integrative Medicine) Ningbo Youth Science and Technology Award Winner Ningbo Leading Talent Macromolecules

Publications

  1. Geniposide plus chlorogenic acid reverses non-alcoholic steatohepatitis via regulation of gut microbiota and bile acid signaling in a mouse model in vivo, Publication date: 2023.
  2. Glial cell line-derived neurotrophic factor (GDNF) mediates hepatic stellate cell activation via ALK5/Smad signalling, Publication date: 2019.
  3. Role of farnesoid X receptor in hepatic steatosis in nonalcoholic fatty liver disease, Publication date: 2020.
  4. Efficacy and Mechanism of a Chinese Classic Prescription of Yueju in Treating Nonalcoholic Steatohepatitis and Protecting Hepatocytes from Apoptosis, Publication date: 2020.
  5. Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota–bile acid–farnesoid X receptor axis, Publication date: 2020.
  6. Gypenosides ameliorate high-fat diet-induced non-alcoholic steatohepatitis via farnesoid X receptor activation, Publication date: 2022.
  7. Intestinal Microecology: An Important Target for Chinese Medicine Treatment of Non-alcoholic Fatty Liver Disease, Publication date: 2020.
  8. Gypenosides ameliorate high-fat diet-induced non-alcoholic steatohepatitis via farnesoid X receptor activation, Publication date: 2022.
.